ROLE OF SERUM ZINC AND SERUM MAGNESIUM IN PROGNOSIS AND OUTCOME OF PATIENTS WITH TRAUMATIC BRAIN INJURY: A PROSPECTIVE STUDY
Main Article Content
Keywords
Traumatic Brain Injury, GCS, GOS, prognosis
Abstract
Traumatic brain injury has been considered as global public health issues. Almost 1.7 million people with isolated or multiple organ damage suffers from traumatic brain injury each year. Severe traumatic brain injury caused secondary multiple organ dysfunction and death. Serum Zinc and serum magnesium level in acute stages after traumatic brain injury (TBI) may be capable of predicting clinical and functional prognosis.
Materials and Methods This prospective study was carried out on 461 TBI patients sample who met the inclusion and exclusion criteria. Sample was collected from clinically diagnosed TBI patients within 24 hrs. Serum zinc and serum magnesium were determined on CST 180 in the central. The association of the serum zinc and serum magnesium determined with severity and outcome post treatment of the TBI patients by chi-square test.
Results: The serum zinc level was found normal range(65-118)µg/dl and serum magnesium level observed normal (1.6-2.4)mgldl except in the age group (51-60) where it was noticed reduced(1.23±0.39)mg/dl .The the association of serum zinc level (p=0.00001) and serum magnesium (p=0.00515) level with the outcome after six month(GOS based) were found significantly associated. Similarly, the association of severity (GCS Based) and Serum level of zinc (0.00001) and serum level of magnesium (0.0515) was also studied and observed significantly associated. Conclusion: The serum zinc level of zinc and serum level of magnesium were found both found significantly associated with both severity and outcomes of the TBI patients. The serum zinc and serum magnesium may play the role in prognosis of the diseases.
References
2. Ministry of Home Affairs, Government of India. National Crime Records Bureau Ministry of Home Affairs. Accidental deaths and suicides in India 2015. 2016. http://ncrb.nic.in/StatPublications/ ADSI/ADSI2015/adsi-2015-full-report.pdf (accessed Sept 20, 2017).
3. Fu, T.S.; Jing, R.; McFaull, S.R.; Cusimano, M.D. Health & Economic Burden of Traumatic Brain Injury in the Emergency Department. Can. J. Neurol. Sci. 2016, 43, 238–247. [CrossRef] [PubMed]
4. Kayani, N.A.; Homan, S.; Yun, S.; Zhu, B.P. Health and economic burden of traumatic brain injury, Missouri, 2001–2005. Public Health Rep. 2009, 124, 551–560. [CrossRef] [PubMed]
5. Guidelines for the management of severe head injury. Brain Trauma Foundation, American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care (1996). J Neurotrauma 13: 641-734.
6. Sen AP, Gulati A. Use of magnesium in traumatic brain injury. Neurotherapeutics: J ASENT. 2010;7:91–9.
7. Ozgurtas T, Kahraman S. State of the art of new data on the role of magnesium in brain injury: Clinical interest of measurements of total and ionized magnesium. Magnesium Res. 2004;17(4):327-34.
8. Vink R. Magnetic resonance spectroscopy. In: Reilly PL, Bullock R. Head injury. 2nd ed. UK: Hodder Arnold Publishing; 2005; p.258-67.
9. Miller LP, Hayes RL. Head trauma basic, preclinical and clinical directions. USA: Wiley–Liss; 2001.
10. Mendoza, D.A.; López, K.D.; Echeverri, R.A.; Pastor, L.; Rueda, S.; Fernández, L.L.; Mantilla, D.S.; Díaz, M.F.; Ramírez, M.C.; Barragán, D.C.; et al. Utility of biomarkers in traumatic brain injury: A narrative review. Colomb. J. Anesthesiol. 2020, 48, 155–161. [CrossRef]
11. Simon, D.W.; McGeachy, M.J.; Bayir, H.; Clark, R.S.; Loane, D.J.; Kochanek, P.M. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol 2017, 13, 171–191. [CrossRef]
12. Dadas, A.; Washington, J.; Diaz-Arrastia, R.; Janigro, D. Biomarkers in traumatic brain injury (TBI): A review. Neuropsychiatr. Dis. Treat. 2018, 14, 2989–3000. [CrossRef]
13. Gower-Winter, S.D.; Levenson, C.W. Zinc in the central nervous system: From molecules to behavior. Bio factors 2012, 38, 186–193.
14. Blakemore, L.J.; Trombley, P.Q. Zinc as a Neuromodulator in the Central Nervous System with a Focus on the Olfactory Bulb. Front. Cell. Neuroscience 2017, 11, 297.
15. Saghazadeh,A.;Ahangari,N.;Hendi,K.;Saleh,F.;Rezaei,N.Statusofessentialelementsinautismspectrumdisorder: Systematic review and meta-analysis. Rev. Neuroscience. 2017, 28, 783–809.
16. Isaev, N.K.; Stelmashook, E.V.; Genrikhs, E.E. Role of zinc and copper ions in the pathogenetic mechanisms of traumatic brain injury and Alzheimer’s disease. Rev. Neuroscience. 2020, 31, 233–243.
17. Choi, S.; Hong, D.K.; Choi, B.Y.; Suh, S.W. Zinc in the Brain: Friend or Foe? Int. J. Mol. Sci. 2020, 21, 8941.
18. Choi, B.Y.; Kim, J.H.; Kim, H.J.; Lee, B.E.; Kim, I.Y.; Sohn, M.; Suh, S.W. Zinc chelation reduces traumatic brain injury-induced neurogenesis in the subgranular zone of the hippocampal dentate gyrus. J. TraceElem. Med. Biol. 2014, 28, 474–481.
19. Hellmich, H.L.; Edison, K.; Cowart, J.; Crookshanks, J.; Boone, D.K.; Shah, S.; Uchida, T.; DeWitt, D.S.; Prough, D.S. Chelation of neurotoxin zinc levels does not improve neurobehavioral outcome after traumatic brain injury. Neuroscience. Lett. 2008, 440, 155–159.
20. Suh, S.W.; Chen, J.W.; Motamedi, M.; Bell, B.; Listiak, K.; Pons, N.F.; Danscher, G.; Frederickson, C.J. Evidence that synaptically released zinc contributes to neuronal injury after traumatic brain injury. Brain Res. 2000, 852, 268–273.
21. Yeiser, E.C.; Vanlandingham, J.W.; Levenson, C.W. Moderate zinc deficiency increases cell death after brain injury in the rat. Nutr. Neuroscience. 2002, 5, 345–352.
22. Dhandapani, S. S., Gupta, A., Vivekanandhan, S., Mahapatra, A. K. and Mehta, V. S., 2005. Serum ionic magnesium in traumatic brain injury. Indian J Neurotrauma, 2 (02), pp.103 - 106.
23. Vink, R., McIntosh, T. K., Demediuk, P. and Faden, A. I., 1987. Decrease in total and free magnesium concentration following traumatic brain injury in rats. Biochemical and biophysical research communications, 149 (2), pp.594 - 599.
24. Saatman, K. E., Bareyre, F. M., Grady, M. S. and McIntosh, T. K., 2001. Acute cytoskeletal alterations and cell death induced by experimental brain injury are attenuated by magnesium treatment and exacerbated by magnesium deficiency. Journal of Neuropathology & Experimental Neurology, 60 (2), pp.183 - 194.
25. Giza, C. C. and Hovda, D. A., 2001. The neurometabolic cascade of concussion. Journal of athletic training, 36 (3), p.228.
26. Kim, K.H.; Ro, Y.S.; Yoon, H.; Lee, S.G.W.; Jung, E.; Moon, S.B.; Park, G.J.; Shin, S.D. Serum Zinc and Long-Term Prognosis after Acute Traumatic Brain Injury with Intracranial Injury: A Multicenter Prospective Study. J. Clin. Med. 2022, 11, 6496. https:// doi.org/10.3390/jcm11216496
27. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. Lancet 1974; 81-84.
28. Pettigrew LE, Wilson JT, Teasdale GM. Reliability of ratings on the Glasgow Outcome Scales from in-person and telephone structured interviews. J Head Trauma Rehabilitation. 2003 May-Jun; 18(3):252-8. doi: 10.1097/00001199-200305000-00003. PMID: 12802167.
29. Levenson, C.W. Zinc and Traumatic Brain Injury: From Chelation to Supplementation. Med. Sci. 2020, 8, 36. https://doi.org/10.3390/medsci8030036.
30. Solati, Z.; Jazayeri, S.; Tehrani-Doost, M.; Mahmoodianfard, S.; Gohari, M.R. Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: A double-blind, randomized, placebo-controlled trial. Nutr. Neuroscience. 2015, 18, 162–168. https://doi.org/10.1179/1476830513Y.0000000105
31. Al-Adhami NK, Al-Rawi WWH, Ibrahem AK. Estimation of some trace elements in severe head injury patients. Fac Med Baghdad 2007;49(4): 482-489.
32. Mohammad Rashid1, Vinod Jain, Samir Misra, Rajesh Kumar Suman. Assessment of Serum Level of Copper, Magnesium, Zinc and Chromium and Its Association with Severity of Head Injury in Trauma Patients.2015:14(04):96-101
33. Nayak, et al.: Serum magnesium in severe traumatic brain injury patients.2018;13(3):685-688
34. Polderman, Kees H. MD, PhD; Bloemers, Frank W. MD; Peerdeman, Saskia M. MD; Girbes, Armand R. J. MD, PhD. Hypomagnesemia and hypophosphatemia at admission in patients with severe head injury. Critical Care Medicine 28(6):p 2022-2025, June 2000.
35. Ghasemi A, Zahediasl S, Azizi F. Reference’s values for serum magnesium levels in young adult’s Iranian subjects. Biol trace Elem Res. 2010; 138(13):99-106.